Rate My Professor Laura Gray

Her research specializes in the identification, prevention, and management of Type 2 Diabetes Mellitus and other long-term conditions through complex interventions, combined with methodological expertise in the design and analysis of clinical trials—particularly cluster and stepped wedge designs—development and validation of prognostic models, and evidence synthesis. Professor Gray has co-authored over 200 peer-reviewed papers, with 138 published in the last 10 years, achieving a Google Scholar h-index of 54 and more than 12,000 citations. Her publications have influenced policy, appearing in 48 documents including WHO reports, UK Government guidelines, NICE and SIGN recommendations, and European Agency for Safety and Health at Work publications. Notable works include 'Mind the gap: covariate constrained randomisation can protect against substantial power loss in parallel cluster randomised trials' (BMC Medical Research Methodology, 2022), 'Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis' (EClinicalMedicine, 2020), and 'Effectiveness of the Stand More AT (SMArT) Work intervention: cluster randomised controlled trial' (BMJ, 2018). As co-investigator, she contributes to major grants such as MiFoot (NIHR Programme Grants, £2.138 million), M3 Research Programme (£2.571 million), and UK-REACH (£2.129 million). A Fellow of the Higher Education Academy since 2014, she leads teaching on the MSc Medical Statistics and MRes Applied Health Research programmes and supervises PhD students on topics including complex evidence synthesis and diabetes screening in dental practices. She serves as External Examiner for the University of Oxford's MSc Global Health Science & Epidemiology.